Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
iRhythm sees Q2 sequential volume growth of approximately 4% » 17:20
05/06/21
05/06
17:20
05/06/21
17:20
IRTC

iRhythm

$74.89 /

+0.14 (+0.19%)

For the second quarter…

For the second quarter 2021, iRhythm expects sequential volume growth of approximately 4% over the first quarter of 2021 and OPEX to be approximately flat to first quarter 2021 with reductions in stock-based compensation and payroll taxes offset by increases in legal and consulting spending and hiring to support investments.

ShowHide Related Items >><<
IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
04/12/21 JPMorgan
JPMorgan downgrades iRhythm, sees 'challenging path' after Novitas decision
IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

  • 19
    Aug
IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

Earnings
iRhythm reports Q1 EPS (95c), consensus (83c) » 17:18
05/06/21
05/06
17:18
05/06/21
17:18
IRTC

iRhythm

$74.89 /

+0.14 (+0.19%)

Reports Q1 revenue $74.3M…

Reports Q1 revenue $74.3M , consensus $70.31M. "The clinical and economic value of our Zio service continues to drive strong demand and generated record volumes in the first quarter. Volumes were 31% above pre-COVID levels seen in the first quarter of 2020, powered primarily by Zio XT in the U.S., while Zio AT in the U.S. and Zio XT in the UK outpaced overall company growth on a percentage basis," said Mike Coyle, iRhythm President and CEO. "As we look forward, our differentiated technology and the enthusiasm we are seeing from both physicians and patients gives confidence in iRhythm's continued market leadership. "We remain steadfast in our pursuit of higher Medicare reimbursement that is more in line with the significant benefits that Zio XT provides. We are also realistic about what direction reimbursement dynamics may take. Accordingly, we are focused on instilling greater discipline across our organization to increase efficiency in our manufacturing, clinical operations, revenue cycle management and sales and marketing functions. "Investing in long term growth, including international expansion and expanding indications of use, remains a top priority, and importantly, we have the financial strength to execute on these opportunities. While we face headwinds, iRhythm has the foundation in place to deliver meaningful value creation."

ShowHide Related Items >><<
IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
04/12/21 JPMorgan
JPMorgan downgrades iRhythm, sees 'challenging path' after Novitas decision
IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

  • 19
    Aug
IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

IRTC iRhythm
$74.89 /

+0.14 (+0.19%)

Wednesday
Periodicals
iRhythm mentioned as possible activist target by Activist Insight » 09:50
05/05/21
05/05
09:50
05/05/21
09:50
IRTC

iRhythm

$72.81 /

+0.59 (+0.82%)

iRhythm is "in…

iRhythm is "in Activist Insight Vulnerability's 100th percentile of companies most likely to be targeted by an activist investor in the next nine months," the publication told its subscribers, according to contacts. Activist Insight cites "a share price that continues to worsen and a board that is consistently losing shareholder support," as well as the company's "esteemed product and a business model that had been working well thus far," according to contacts.

ShowHide Related Items >><<
IRTC iRhythm
$72.81 /

+0.59 (+0.82%)

IRTC iRhythm
$72.81 /

+0.59 (+0.82%)

04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
04/12/21 JPMorgan
JPMorgan downgrades iRhythm, sees 'challenging path' after Novitas decision
IRTC iRhythm
$72.81 /

+0.59 (+0.82%)

  • 19
    Aug
IRTC iRhythm
$72.81 /

+0.59 (+0.82%)

Over a week ago
Downgrade
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley » 07:03
04/14/21
04/14
07:03
04/14/21
07:03
IRTC

iRhythm

$85.71 /

+5.8 (+7.26%)

Morgan Stanley analyst…

Morgan Stanley analyst Cecilia Furlong downgraded iRhythm to Equal Weight from Overweight with a price target of $94, down from $288, as she assumed primary coverage of the stock. Novitas published rates for CPT codes 93243 and 93247 that represent a 64% blended cut to the Medicare contractor's prior rates, noted Furlong, who said iRhythm "had little choice but to pull XT out of the market." While she said she doesn't agree with Novitas' decision, visibility on competitor response and whether CMS will take action is limited, the analyst tells investors.

ShowHide Related Items >><<
IRTC iRhythm
$85.71 /

+5.8 (+7.26%)

IRTC iRhythm
$85.71 /

+5.8 (+7.26%)

04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
04/12/21 JPMorgan
JPMorgan downgrades iRhythm, sees 'challenging path' after Novitas decision
04/12/21 JPMorgan
iRhythm downgraded to Neutral from Overweight at JPMorgan
IRTC iRhythm
$85.71 /

+5.8 (+7.26%)

  • 19
    Aug
IRTC iRhythm
$85.71 /

+5.8 (+7.26%)

Recommendations
iRhythm price target lowered to $115 from $220 at Truist » 08:07
04/13/21
04/13
08:07
04/13/21
08:07
IRTC

iRhythm

$80.24 /

-52.54 (-39.57%)

Truist analyst Kaila Krum…

Truist analyst Kaila Krum lowered the firm's price target on iRhythm to $115 from $220 and keeps a Buy rating on the shares. The stock fell about 40% yesterday after its announced intent to no longer provide its ZioXT service to the Medicare fee for service segment, which follows the decision by Novitas to price the service at $103-$115, the analyst tells investors in a research note. Krum adds however that the risk-reward on iRhythm is still good at $80; and that while the bull thesis has been "damaged", it's certainly "not broken".

ShowHide Related Items >><<
IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
04/12/21 JPMorgan
JPMorgan downgrades iRhythm, sees 'challenging path' after Novitas decision
04/12/21 JPMorgan
iRhythm downgraded to Neutral from Overweight at JPMorgan
04/12/21 Baird
iRhythm price target lowered to $80 from $170 at Baird
IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

  • 19
    Aug
IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

Downgrade
iRhythm downgraded to Neutral from Buy at BTIG » 05:45
04/13/21
04/13
05:45
04/13/21
05:45
IRTC

iRhythm

$80.24 /

-52.54 (-39.57%)

BTIG analyst Marie…

BTIG analyst Marie Thibault downgraded iRhythm Technologies to Neutral from Buy without a price target. As a follow-up to the new Novitas rates published this weekend, iRhythm has said that if the rate is not increased, it will not be able to offer Zio XT to the Medicare population since the rate is lower than the cost of delivering service, Thibault tells investors in a research note. The analyst does not see "any quick fixes" and believes there are "major risks to consider," including the possibility that commercial payers could try to reduce their rates. Thibault reduced her revenue forecast "meaningfully" and downgraded iRhythm after balancing the "downside risks of uncertain timelines, potential for further payer cuts and possible competitive dynamics against the possibility of an eventual positive resolution and strong underlying volume."

ShowHide Related Items >><<
IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

04/12/21 JPMorgan
JPMorgan downgrades iRhythm, sees 'challenging path' after Novitas decision
04/12/21 JPMorgan
iRhythm downgraded to Neutral from Overweight at JPMorgan
04/12/21 Baird
iRhythm price target lowered to $80 from $170 at Baird
04/12/21 BTIG
BTIG puts iRhythm Buy rating under review after reimbursement cut
IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

  • 19
    Aug
IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:40
04/12/21
04/12
16:40
04/12/21
16:40
NUAN

Nuance

$52.80 /

+7.21 (+15.81%)

, MSFT

Microsoft

$255.89 /

+0.16 (+0.06%)

, DSRLF

DiaSorin SpA

$165.82 /

+ (+0.00%)

, LMNX

Luminex

$37.03 /

+4.11 (+12.48%)

, IR

Ingersoll-Rand

$50.14 /

-0.41 (-0.81%)

, BABA

Alibaba

$244.24 /

+20.89 (+9.35%)

, UBER

Uber

$59.44 /

+1.72 (+2.98%)

, NVDA

Nvidia

$608.46 /

+33.14 (+5.76%)

, AMD

AMD

$78.62 /

-4.1 (-4.96%)

, INTC

Intel

$65.41 /

-2.85 (-4.18%)

, GME

GameStop

$141.04 /

-17 (-10.76%)

, RIOT

Riot Blockchain

$51.54 /

+1.87 (+3.76%)

, SIG

Signet Jewelers

$65.85 /

+4.76 (+7.79%)

, IRTC

iRhythm

$80.24 /

-52.54 (-39.57%)

, APHA

Aphria

$13.93 /

-2.34 (-14.38%)

The major averages closed…

ShowHide Related Items >><<
UBER Uber
$59.44 /

+1.72 (+2.98%)

SIG Signet Jewelers
$65.85 /

+4.76 (+7.79%)

RIOT Riot Blockchain
$51.54 /

+1.87 (+3.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

LMNX Luminex
$37.03 /

+4.11 (+12.48%)

IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

IR Ingersoll-Rand
$50.14 /

-0.41 (-0.81%)

INTC Intel
$65.41 /

-2.85 (-4.18%)

GME GameStop
$141.04 /

-17 (-10.76%)

DSRLF DiaSorin SpA
$165.82 /

+ (+0.00%)

BABA Alibaba
$244.24 /

+20.89 (+9.35%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

AMD AMD
$78.62 /

-4.1 (-4.96%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

04/13/21 Craig-Hallum
Nuance downgraded to Hold from Buy at Craig-Hallum
04/13/21 Wedbush
Nuance downgraded to Neutral at Wedbush on Microsoft deal
04/13/21 Argus
Microsoft price target raised to $300 from $275 at Argus
04/13/21 BMO Capital
BMO Capital positive on Microsoft deal for Nuance
MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

DSRLF DiaSorin SpA
$165.82 /

+ (+0.00%)

03/24/21 Berenberg
DiaSorin SpA price target lowered to EUR 150 from EUR 180 at Berenberg
03/18/21 Morgan Stanley
DiaSorin SpA downgraded to Underweight from Equal Weight at Morgan Stanley
12/10/20 Exane BNP Paribas
DiaSorin SpA price target raised to EUR 145 from EUR 135 at Exane BNP Paribas
12/10/20 Kepler Cheuvreux
DiaSorin SpA upgraded to Buy from Hold at Kepler Cheuvreux
LMNX Luminex
$37.03 /

+4.11 (+12.48%)

04/13/21 Piper Sandler
Luminex downgraded to Neutral from Overweight at Piper Sandler
04/13/21 BTIG
Luminex downgraded to Neutral from Buy at BTIG
04/12/21 JPMorgan
Luminex upgraded to Neutral from Underweight at JPMorgan
02/18/21 Piper Sandler
Luminex shares are undervalued, says Piper Sandler
IR Ingersoll-Rand
$50.14 /

-0.41 (-0.81%)

04/06/21 Barclays
Ingersoll-Rand price target raised to $56 from $53 at Barclays
02/24/21 Deutsche Bank
Ingersoll-Rand price target raised to $50 from $47 at Deutsche Bank
02/16/21 UBS
Ingersoll-Rand's deal to sell HPS interest 'positive,' says UBS
01/15/21 Jefferies
Ingersoll-Rand price target raised to $53 from $45 at Jefferies
BABA Alibaba
$244.24 /

+20.89 (+9.35%)

04/13/21 Baird
Alibaba fines more benign than feared, says Baird
04/12/21 CLSA
Alibaba price target lowered to $320 from $351 at CLSA
04/12/21 Morgan Stanley
Alibaba named a Research Tactical Idea at Morgan Stanley
04/12/21 Raymond James
Alibaba price target lowered to $330 from $350 at Raymond James
UBER Uber
$59.44 /

+1.72 (+2.98%)

04/12/21 Truist
Uber's March update 'bodes well' for Q1 and FY21 outlook, says Truist
04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Jefferies
Uber initiated with a Buy at Jefferies
NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

04/13/21 Wells Fargo
Nvidia price target raised to $715 from $625 at Wells Fargo
04/13/21 Cowen
Nvidia price target raised to $675 from $665 at Cowen
04/13/21 Credit Suisse
Nvidia price target raised to $700 from $620 at Credit Suisse
04/13/21 Deutsche Bank
Nvidia price target raised to $575 from $560 at Deutsche Bank
AMD AMD
$78.62 /

-4.1 (-4.96%)

04/12/21 Lynx
Intel, AMD selloffs on Nvidia 'Grace' news a buying opportunity, says Lynx
04/06/21 Raymond James
Performance gap between Intel, AMD 'remains massive,' says Raymond James
03/25/21
Fly Intel: Top five analyst upgrades
03/25/21 Northland
Northland upgrades AMD to Outperform on Intel's 'strategic faux pas'
INTC Intel
$65.41 /

-2.85 (-4.18%)

04/13/21 Susquehanna
Nvidia to invest heavily into data center space, says Susquehanna
04/06/21 Roth Capital
Roth encouraged by Intel's progress so far this year
GME GameStop
$141.04 /

-17 (-10.76%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 Ascendiant
GameStop downgraded to Sell from Hold at Ascendiant
04/06/21 BofA
BofA keeps $10 target on GameStop despite 'positive' funding news
04/05/21 Telsey Advisory
Telsey keeps Underperform rating on GameStop after Q1 update, ATM program bump
RIOT Riot Blockchain
$51.54 /

+1.87 (+3.76%)

11/23/20 H.C. Wainwright
Riot Blockchain price target raised to $7.50 from $3.50 at H.C. Wainwright
SIG Signet Jewelers
$65.85 /

+4.76 (+7.79%)

01/15/21 Citi
Signet Jewelers price target raised to $45 from $40 at Citi
01/12/21 Citi
Signet Jewelers upgraded to Neutral from Sell at Citi
01/08/21 Northcoast
Signet Jewelers upgraded to Buy from Neutral at Northcoast
09/04/20 Citi
Signet Jewelers price target raised to $12 from $5 at Citi
IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
04/12/21 JPMorgan
JPMorgan downgrades iRhythm, sees 'challenging path' after Novitas decision
04/12/21 JPMorgan
iRhythm downgraded to Neutral from Overweight at JPMorgan
APHA Aphria
$13.93 /

-2.34 (-14.38%)

04/13/21 Canaccord
Aphria downgraded to Hold on industry headwinds at Canaccord
04/13/21 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
04/12/21 Alliance Global Partners
Alliance Global trims Aphria price target to C$24, says long-term view intact
04/08/21 Alliance Global Partners
Aphria price target raised to $26 from $20 at Alliance Global Partners
UBER Uber
$59.44 /

+1.72 (+2.98%)

SIG Signet Jewelers
$65.85 /

+4.76 (+7.79%)

RIOT Riot Blockchain
$51.54 /

+1.87 (+3.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

LMNX Luminex
$37.03 /

+4.11 (+12.48%)

IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

IR Ingersoll-Rand
$50.14 /

-0.41 (-0.81%)

INTC Intel
$65.41 /

-2.85 (-4.18%)

GME GameStop
$141.04 /

-17 (-10.76%)

BABA Alibaba
$244.24 /

+20.89 (+9.35%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

AMD AMD
$78.62 /

-4.1 (-4.96%)

  • 08
    Jan
  • 19
    Aug
  • 17
    Jun
UBER Uber
$59.44 /

+1.72 (+2.98%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

LMNX Luminex
$37.03 /

+4.11 (+12.48%)

IR Ingersoll-Rand
$50.14 /

-0.41 (-0.81%)

INTC Intel
$65.41 /

-2.85 (-4.18%)

GME GameStop
$141.04 /

-17 (-10.76%)

DSRLF DiaSorin SpA
$165.82 /

+ (+0.00%)

BABA Alibaba
$244.24 /

+20.89 (+9.35%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

AMD AMD
$78.62 /

-4.1 (-4.96%)

UBER Uber
$59.44 /

+1.72 (+2.98%)

SIG Signet Jewelers
$65.85 /

+4.76 (+7.79%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

LMNX Luminex
$37.03 /

+4.11 (+12.48%)

IRTC iRhythm
$80.24 /

-52.54 (-39.57%)

INTC Intel
$65.41 /

-2.85 (-4.18%)

GME GameStop
$141.04 /

-17 (-10.76%)

BABA Alibaba
$244.24 /

+20.89 (+9.35%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

AMD AMD
$78.62 /

-4.1 (-4.96%)

UBER Uber
$59.44 /

+1.72 (+2.98%)

SIG Signet Jewelers
$65.85 /

+4.76 (+7.79%)

RIOT Riot Blockchain
$51.54 /

+1.87 (+3.76%)

NVDA Nvidia
$608.46 /

+33.14 (+5.76%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

INTC Intel
$65.41 /

-2.85 (-4.18%)

GME GameStop
$141.04 /

-17 (-10.76%)

BABA Alibaba
$244.24 /

+20.89 (+9.35%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

AMD AMD
$78.62 /

-4.1 (-4.96%)

Downgrade
JPMorgan downgrades iRhythm, sees 'challenging path' after Novitas decision » 13:46
04/12/21
04/12
13:46
04/12/21
13:46
IRTC

iRhythm

$82.95 /

-49.83 (-37.53%)

JPMorgan analyst Robbie…

JPMorgan analyst Robbie Marcus downgraded iRhythm to Neutral from Overweight with a price target of $95, down from $215, after Medicare administrative contractor Novitas Solutions published updated reimbursement rates that he notes are higher than those published in January but "substantially lower" than the prior $311 rate and unprofitable at the new level to iRhythm. He expects this "short-sighted decision" by Novitas to eventually be reversed, whether by Novitas themselves, through a higher national rate, or via another MAC, but he doesn't expect a favorable resolution in the near-term and he sees a "challenging path" ahead for iRhythm, Marcus tells investors.

ShowHide Related Items >><<
IRTC iRhythm
$82.95 /

-49.83 (-37.53%)

IRTC iRhythm
$82.95 /

-49.83 (-37.53%)

04/12/21 JPMorgan
iRhythm downgraded to Neutral from Overweight at JPMorgan
04/12/21 Baird
iRhythm price target lowered to $80 from $170 at Baird
04/12/21 BTIG
BTIG puts iRhythm Buy rating under review after reimbursement cut
03/01/21 Citi
iRhythm price target lowered to $195 from $252 at Citi
IRTC iRhythm
$82.95 /

-49.83 (-37.53%)

  • 19
    Aug
IRTC iRhythm
$82.95 /

-49.83 (-37.53%)

Downgrade
iRhythm downgraded to Neutral from Overweight at JPMorgan » 13:39
04/12/21
04/12
13:39
04/12/21
13:39
IRTC

iRhythm

$82.24 /

-50.54 (-38.06%)

JPMorgan analyst Robbie…

JPMorgan analyst Robbie Marcus downgraded iRhythm to Neutral from Overweight with a price target of $95, down from $215.

ShowHide Related Items >><<
IRTC iRhythm
$82.24 /

-50.54 (-38.06%)

IRTC iRhythm
$82.24 /

-50.54 (-38.06%)

04/12/21 Baird
iRhythm price target lowered to $80 from $170 at Baird
04/12/21 BTIG
BTIG puts iRhythm Buy rating under review after reimbursement cut
03/01/21 Citi
iRhythm price target lowered to $195 from $252 at Citi
02/26/21 Colliers
iRhythm downgraded to Neutral from Buy at Colliers
IRTC iRhythm
$82.24 /

-50.54 (-38.06%)

  • 19
    Aug
IRTC iRhythm
$82.24 /

-50.54 (-38.06%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:55
04/12/21
04/12
12:55
04/12/21
12:55
MSFT

Microsoft

$257.29 /

+1.56 (+0.61%)

, NUAN

Nuance

$52.98 /

+7.39 (+16.21%)

, BABA

Alibaba

$243.35 /

+20 (+8.95%)

, LMNX

Luminex

$36.82 /

+3.9 (+11.85%)

, UBER

Uber

$60.02 /

+2.3 (+3.98%)

, IR

Ingersoll-Rand

$50.40 /

-0.15 (-0.30%)

, DSRLF

DiaSorin SpA

$165.82 /

+0.8151 (+0.49%)

, RIOT

Riot Blockchain

$53.92 /

+4.25 (+8.56%)

, SIG

Signet Jewelers

$65.11 /

+4.02 (+6.58%)

, IRTC

iRhythm

$83.64 /

-49.14 (-37.01%)

, APHA

Aphria

$14.12 /

-2.15 (-13.21%)

The major averages are…

ShowHide Related Items >><<
UBER Uber
$60.02 /

+2.3 (+3.98%)

SIG Signet Jewelers
$65.11 /

+4.02 (+6.58%)

RIOT Riot Blockchain
$53.92 /

+4.25 (+8.56%)

NUAN Nuance
$52.98 /

+7.39 (+16.21%)

MSFT Microsoft
$257.29 /

+1.56 (+0.61%)

LMNX Luminex
$36.82 /

+3.9 (+11.85%)

IRTC iRhythm
$83.64 /

-49.14 (-37.01%)

IR Ingersoll-Rand
$50.40 /

-0.15 (-0.30%)

BABA Alibaba
$243.35 /

+20 (+8.95%)

APHA Aphria
$14.12 /

-2.15 (-13.21%)

MSFT Microsoft
$257.29 /

+1.56 (+0.61%)

04/12/21 Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
04/12/21 B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
04/12/21 Wedbush
Nuance deal would be 'trophy' for Microsoft, says Wedbush
04/12/21 BMO Capital
Microsoft price target raised to $280 from $270 at BMO Capital
NUAN Nuance
$52.98 /

+7.39 (+16.21%)

03/10/21 Wedbush
Nuance added to Best Ideas List at Wedbush
BABA Alibaba
$243.35 /

+20 (+8.95%)

04/12/21 CLSA
Alibaba price target lowered to $320 from $351 at CLSA
04/12/21 Morgan Stanley
Alibaba named a Research Tactical Idea at Morgan Stanley
04/12/21 Raymond James
Alibaba price target lowered to $330 from $350 at Raymond James
04/12/21 Mizuho
Alibaba antitrust ruling 'removes overhang,' says Mizuho
LMNX Luminex
$36.82 /

+3.9 (+11.85%)

02/18/21 Piper Sandler
Luminex shares are undervalued, says Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
UBER Uber
$60.02 /

+2.3 (+3.98%)

04/12/21 Truist
Uber's March update 'bodes well' for Q1 and FY21 outlook, says Truist
04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Jefferies
Uber initiated with a Buy at Jefferies
IR Ingersoll-Rand
$50.40 /

-0.15 (-0.30%)

04/06/21 Barclays
Ingersoll-Rand price target raised to $56 from $53 at Barclays
02/24/21 Deutsche Bank
Ingersoll-Rand price target raised to $50 from $47 at Deutsche Bank
02/16/21 UBS
Ingersoll-Rand's deal to sell HPS interest 'positive,' says UBS
01/15/21 Jefferies
Ingersoll-Rand price target raised to $53 from $45 at Jefferies
DSRLF DiaSorin SpA
$165.82 /

+0.8151 (+0.49%)

03/24/21 Berenberg
DiaSorin SpA price target lowered to EUR 150 from EUR 180 at Berenberg
03/18/21 Morgan Stanley
DiaSorin SpA downgraded to Underweight from Equal Weight at Morgan Stanley
12/10/20 Exane BNP Paribas
DiaSorin SpA price target raised to EUR 145 from EUR 135 at Exane BNP Paribas
12/10/20 Kepler Cheuvreux
DiaSorin SpA upgraded to Buy from Hold at Kepler Cheuvreux
RIOT Riot Blockchain
$53.92 /

+4.25 (+8.56%)

11/23/20 H.C. Wainwright
Riot Blockchain price target raised to $7.50 from $3.50 at H.C. Wainwright
SIG Signet Jewelers
$65.11 /

+4.02 (+6.58%)

01/15/21 Citi
Signet Jewelers price target raised to $45 from $40 at Citi
01/12/21 Citi
Signet Jewelers upgraded to Neutral from Sell at Citi
01/08/21 Northcoast
Signet Jewelers upgraded to Buy from Neutral at Northcoast
09/04/20 Citi
Signet Jewelers price target raised to $12 from $5 at Citi
IRTC iRhythm
$83.64 /

-49.14 (-37.01%)

04/12/21 Baird
iRhythm price target lowered to $80 from $170 at Baird
04/12/21 BTIG
BTIG puts iRhythm Buy rating under review after reimbursement cut
03/01/21 Citi
iRhythm price target lowered to $195 from $252 at Citi
02/26/21 Colliers
iRhythm downgraded to Neutral from Buy at Colliers
APHA Aphria
$14.12 /

-2.15 (-13.21%)

04/08/21 Alliance Global Partners
Aphria price target raised to $26 from $20 at Alliance Global Partners
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/22/21 CIBC
Aphria price target raised to C$28 from C$18 at CIBC
UBER Uber
$60.02 /

+2.3 (+3.98%)

SIG Signet Jewelers
$65.11 /

+4.02 (+6.58%)

RIOT Riot Blockchain
$53.92 /

+4.25 (+8.56%)

NUAN Nuance
$52.98 /

+7.39 (+16.21%)

MSFT Microsoft
$257.29 /

+1.56 (+0.61%)

LMNX Luminex
$36.82 /

+3.9 (+11.85%)

IRTC iRhythm
$83.64 /

-49.14 (-37.01%)

IR Ingersoll-Rand
$50.40 /

-0.15 (-0.30%)

BABA Alibaba
$243.35 /

+20 (+8.95%)

APHA Aphria
$14.12 /

-2.15 (-13.21%)

  • 08
    Jan
  • 19
    Aug
  • 17
    Jun
UBER Uber
$60.02 /

+2.3 (+3.98%)

MSFT Microsoft
$257.29 /

+1.56 (+0.61%)

LMNX Luminex
$36.82 /

+3.9 (+11.85%)

IR Ingersoll-Rand
$50.40 /

-0.15 (-0.30%)

BABA Alibaba
$243.35 /

+20 (+8.95%)

APHA Aphria
$14.12 /

-2.15 (-13.21%)

UBER Uber
$60.02 /

+2.3 (+3.98%)

SIG Signet Jewelers
$65.11 /

+4.02 (+6.58%)

RIOT Riot Blockchain
$53.92 /

+4.25 (+8.56%)

NUAN Nuance
$52.98 /

+7.39 (+16.21%)

MSFT Microsoft
$257.29 /

+1.56 (+0.61%)

LMNX Luminex
$36.82 /

+3.9 (+11.85%)

IRTC iRhythm
$83.64 /

-49.14 (-37.01%)

BABA Alibaba
$243.35 /

+20 (+8.95%)

APHA Aphria
$14.12 /

-2.15 (-13.21%)

UBER Uber
$60.02 /

+2.3 (+3.98%)

SIG Signet Jewelers
$65.11 /

+4.02 (+6.58%)

RIOT Riot Blockchain
$53.92 /

+4.25 (+8.56%)

NUAN Nuance
$52.98 /

+7.39 (+16.21%)

MSFT Microsoft
$257.29 /

+1.56 (+0.61%)

BABA Alibaba
$243.35 /

+20 (+8.95%)

APHA Aphria
$14.12 /

-2.15 (-13.21%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.